Panitumumab in Metastatic Colorectal Cancer: The Importance of Tumour RAS Status

Tumour biomarker status is being used more and more frequently to guide treatment decisions in patients with metastatic colorectal cancer (mCRC). Continued cycles of hypothesis generation and biomarker testing in retrospective, prospective–retrospective and prospective analyses from studies of the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Peeters, Marc, Karthaus, Meinolf, Rivera, Fernando, Terwey, Jan-Henrik, Douillard, Jean-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419154/
https://www.ncbi.nlm.nih.gov/pubmed/25895463
http://dx.doi.org/10.1007/s40265-015-0386-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419154/
https://www.ncbi.nlm.nih.gov/pubmed/25895463
http://dx.doi.org/10.1007/s40265-015-0386-x

Ejemplares similares